RGLS REGULUS THERAPEUTICS INC Management Changes 8-K Filing 2023 - Appointment of President and Head of R&D Regulus Therapeutics Inc. appointed Preston Klassen as President and Head of R&D, with details of his employment agreement and compensation.Get access to all SEC 8-K filings of the REGULUS THERAPEUTICS INC